0001507673-22-000015.txt : 20220810
0001507673-22-000015.hdr.sgml : 20220810
20220810151256
ACCESSION NUMBER: 0001507673-22-000015
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
EFFECTIVENESS DATE: 20220810
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RP Management, LLC
CENTRAL INDEX KEY: 0001507673
IRS NUMBER: 611450238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19261
FILM NUMBER: 221151567
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001507673
XXXXXXXX
06-30-2022
06-30-2022
RP Management, LLC
110 East 59th Street
Suite 3300
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-19261
N
Jason Mehar
VP, Investments & Deputy General Counsel
212-883-0200
/s/ Jason Mehar
New York
NY
08-10-2022
1
5
253203
false
1
0001507678
028-19630
Legorreta Pablo G.
INFORMATION TABLE
2
information_table.xml
INFORMATION TABLE
BIOHAVEN PHARMACTL HLDG CO L
COM
G11196105
161900
1111111
SH
DFND
1
1111111
0
0
VIRACTA THERAPEUTICS INC
COM
92765F108
18
3700
SH
DFND
1
3700
0
0
EPIZYME INC
COM
29428V104
46807
31841394
SH
DFND
1
31841394
0
0
EPIZYME INC
COM
29428V904
3786
2575450
SH
Call
DFND
1
2575450
0
0
BIOCRYST PHARMACEUTICALS INC
COM
09058V103
40692
3846154
SH
DFND
1
3846154
0
0